Mundo E - Search Results

1

Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.

Mundo E, Bianchi L, Bellodi L. Mundo E, et al. J Clin Psychopharmacol. 1997 Aug;17(4):267-71. doi: 10.1097/00004714-199708000-00005. J Clin Psychopharmacol. 1997. PMID: 9241005 Clinical Trial.

2

Follow-up of obsessive-compulsive patients treated with proserotonergic agents.

Mundo E, Erzegovesi S, Bellodi L. Mundo E, et al. J Clin Psychopharmacol. 1995 Aug;15(4):288-9. doi: 10.1097/00004714-199508000-00012. J Clin Psychopharmacol. 1995. PMID: 7593716 Clinical Trial. No abstract available.

3

Effects of acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment.

Mundo E, Bellodi L, Smeraldi E. Mundo E, et al. Biol Psychiatry. 1995 Oct 15;38(8):525-31. doi: 10.1016/0006-3223(94)00373-B. Biol Psychiatry. 1995. PMID: 8562664 Clinical Trial.

4

Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study.

Mundo E, Bareggi SR, Pirola R, Bellodi L, Smeraldi E. Mundo E, et al. J Clin Psychopharmacol. 1997 Feb;17(1):4-10. doi: 10.1097/00004714-199702000-00002. J Clin Psychopharmacol. 1997. PMID: 9004050 Clinical Trial.

5

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.

Mundo E, Guglielmo E, Bellodi L. Mundo E, et al. Int Clin Psychopharmacol. 1998 Sep;13(5):219-24. doi: 10.1097/00004850-199809000-00005. Int Clin Psychopharmacol. 1998. PMID: 9817627 Clinical Trial.

6

Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable?

Mundo E, Bareggi SR, Pirola R, Bellodi L. Mundo E, et al. Biol Psychiatry. 1999 Feb 1;45(3):290-4. doi: 10.1016/s0006-3223(98)00027-4. Biol Psychiatry. 1999. PMID: 10023504 Clinical Trial.

7

Are gender differences in antiobsessional response related to different clomipramine metabolism?

Mundo E, Pirola R, Bellodi L, Smeraldi E, Bareggi SR. Mundo E, et al. J Clin Psychopharmacol. 2002 Jun;22(3):341-2. doi: 10.1097/00004714-200206000-00021. J Clin Psychopharmacol. 2002. PMID: 12006911 No abstract available.

8

The calpain-calpastatin system in obsessive-compulsive disorder.

Mundo E, Soldati L, Bellodi L, Bianchi G. Mundo E, et al. Biol Psychiatry. 1997 Aug 1;42(3):228-9. doi: 10.1016/S0006-3223(97)00251-5. Biol Psychiatry. 1997. PMID: 9232216 No abstract available.

9

Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Mundo E, Maina G, Uslenghi C. Mundo E, et al. Int Clin Psychopharmacol. 2000 Mar;15(2):69-76. doi: 10.1097/00004850-200015020-00002. Int Clin Psychopharmacol. 2000. PMID: 10759337 Clinical Trial.

10

Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction.

Pirola R, Mundo E, Bellodi L, Bareggi SR. Pirola R, et al. Among authors: mundo e. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5;772(2):205-10. doi: 10.1016/s1570-0232(02)00089-2. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12007764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters